These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2956306)

  • 21. Life events, depression and hypothalamic-pituitary-adrenal axis function.
    Dolan RJ; Calloway SP; Fonagy P; De Souza FV; Wakeling A
    Br J Psychiatry; 1985 Oct; 147():429-33. PubMed ID: 4075033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
    Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA
    Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy.
    Maes M; Claes M; Schotte C; Delbeke L; Jacquemyn Y; Verkerk R; De Meester I; Scharpé S
    J Psychosom Res; 1992 Feb; 36(2):191-7. PubMed ID: 1560430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
    Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 29. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A; Holsboer F
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
    Cameron OG; Kronfol Z; Greden JF; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1090-5. PubMed ID: 6497572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
    Yehuda R; Southwick SM; Krystal JH; Bremner D; Charney DS; Mason JW
    Am J Psychiatry; 1993 Jan; 150(1):83-6. PubMed ID: 8417586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
    Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 37. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 39. Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded.
    Sandman CA; Barron JL; Parker L
    Pharmacol Biochem Behav; 1985 Jul; 23(1):21-6. PubMed ID: 4034619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.